Human Papillomavirus Screening and Self-Collected Vaginal Samples
Cet article présente une synthèse des préconisations concernant l'auto-prélèvement vaginal dans le cadre du dépistage du cancer du col de l'utérus
In the US, 14 000 people are diagnosed with cervical cancer and 4000 die of cervical cancer annually, with more than 90% of cases caused by HPV.1 HPV testing reduces cervical cancer incidence and mortality.2 This JAMA Clinical Guidelines Synopsis focuses on recommendations about self-collected vaginal specimens for HPV testing in cervical cancer screening.
JAMA , résumé, 2026